Phase 1 study of ZX007 Tablets in Healthy Subjects. QCL117503

• Research type

  Research Study

• Full title

  Phase 1 study of ZX007 Tablets in Healthy Subjects. QCL117503

• IRAS ID

  167805

• Contact name

  Kevin Romanko

• Sponsor organisation

  Zogenix

• Eudract number

  2014-004528-23

• Duration of Study in the UK

  0 years, 1 months, 22 days

• Research summary

  Research summary not yet available

• REC name

  Wales REC 1

• REC reference

  14/WA/1243

• Date of REC Opinion

  23 Dec 2014

• REC opinion

  Further Information Favourable Opinion